bpc 157 ulcerative colitis phase ii trial 2 of Anti-TL1A Monoclonal Antibody Tulisokibart for 544 published articles on BPC-157.
Description
This rate is driven by ADH enzyme (alcohol dehydrogenase) activity in the liver
and I.O.: formal analysis
The rest is history

Pritts J
